Suppression of alcohol intake by chronic naloxone treatment in P rats: Tolerance development and elevation of opiate receptor binding

Alcoholism: Clinical and Experimental Research

Volumn 23, Issue 11, 1999, Pages 1761-1771

  Overstreet, David H ^a   Kampov Polevoy, Alexey B ^a   Rezvani, Amir H ^a   Braun, Chris ^a   Bartus, Raymond T ^b   Crews, Fulton T ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b ALKERMES INC   (United States)

Author keywords

Alcoholism; Naloxone; P Rats; Pharmacotherapy

Indexed keywords

NALOXONE; OPIATE RECEPTOR;

ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED DRUG RELEASE; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032742936     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1999.tb04071.x     Document Type: Article

References (33)

1. Altschuler HL, Phillips PE, Feinhandler DA (1980) Alterations of ethanol self-administration by naltrexone. Life Sci 26:679-688.
2. Crane SM, Shen KF (1996) Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence. Neurochem Res 21:1347-1351.
3. Creese I, Sibley DR (1981) Receptor adaptations to centrally acting drugs. Annu Rev Pharmacol Toxicol 21:352-391.
4. Croop RS, Faulkner EB, Labriola DF (1997) The safety profile of naltrexone in the treatment of alcoholism: Results for a multicenter usage study. Arch Gen Psychiatry 54:1130-1135.
5. Dewaele JP, Kiianmaa K, Gianoulakis C (1997) Distribution of the μ and ∂ opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats. J Pharmacol Exp Ther 21:745-762.
6. Froehlich JC, Harts J, Lumeng L, Li TK (1990) Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 35:385-390.
7. Gardell LR, Whalen CA, Chattophadyay S, Cavallero CA, Hubell CL, Reid LD (1997) Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcohol Clin Exp Res 21:1435-1439.
8. Goodison T, Siegel S (1995) Tolerance to naloxone-induced suppression of intake: Learning and cross-tolerance to cholecystokinin in rats. Behav Neurosci 109:455-465.
9. Honkanen A, Vilama L, Wegelius K, Sarvharju M, Hyytia P, Korpi ER (1996) Alcohol drinking is reduced by a μ(1)-but not by a ∂-opioid receptor antagonist in alcohol preferring rats. Eur J Pharmacol 304:7-13.
10. Howlett DR, Nahorski SR (1979) Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites. Brain Res 161:173-178.
11. Hubbell CL, Czirr SA, Hunter GA, Beaman CM, LeCann NC, Reid LD (1986) Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol 2:1-16.
12. Hyytia P, Sinclair JD (1993) Responding for oral ethanol after naloxone treatment by alcohol preferring AA rats. Alcohol Clin Exp Res 17:631-636.
13. Iso H, Brush FR (1991) Opposite effects of naltrexone on ETOH intake by Syracuse high and low avoidance rats. Alcohol 8:443-448.
14. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
15. Kornet M, Goosen C, Van Ree JM (1991) Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 104:367-376.
16. Kranzler HR, Modesto-Lowe V, Nuwayser ES (1998) Sustained-release naltrexone for alcoholism treatment: A preliminary study. Alcohol Clin Exp Res 22:1074-1079.
17. Krishnan-Sarin S, Portoghese PS, Li TK, Froehlich JC (1993) The ∂2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav 52:153-159.
18. Krishnan-Sarin S, Wand GS, Li TK, Portoghese PS, Froehlich JC (1998) Effects of μ opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharmacol Biochem Behav 59:627-635.
19. Le AD, Poulos CX, Quan B, Chow S (1993) The effects of selective blockade of ∂ and μ opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res 630:330-332.
20. Markou A, Kosten TR, Koob GF (1998) Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 18:135-174.
21. Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E (1994) A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res 18:1162-1167.
22. McBride WJ, Chernet D, McKinzie DL, Lumeng L, Li TK (1998) Quantitative autoradiography of μ-opioid receptors in the CNS of alcohol-naive alcohol-preferring P and -nonpreferring NP rats. Alcohol 16:317-323.
23. Morris TJ, Millan MJ, Herz A (1988) Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of μ, ∂, and κ binding sites in rat brain revealed by quantitative autoradiography. J Pharmacol Exp Ther 247:729-736.
24. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyre RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 49:881-887.
25. Overstreet DH, Yamamura HI (1979) Receptor alterations and drug tolerance. Life Sci 25:1865-1878.
26. Phillips TJ, Wenger CD, Dorow JD (1997) Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL6J mice. Alcohol Clin Exp Res 21:691-702.
27. 3H] antagonist dopamine receptor binding. Experientia 38:1124-1125.
28. Sinclair JD (1990) Drugs to decrease alcohol drinking. Ann Med 22:357-362.
29. Temple A, Gardner EL, Sukin RS (1985) Neurochemical and functional correlates of naltrexone-induced upregulation and functional supersensitivity. J Pharmacol Exp Ther 232:439-444.
30. Tepperman FS, Hirst M, Smith P (1983) Brain and serum levels of naloxone following peripheral administration. Life Sci 33:1091-1096.
31. Volpicelli JP, Alterman AI, Hyashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880.
32. Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP (1997) Naltrexone and alcohol dependence: Role of subject compliance. Arch Gen Psychiatry 54:737-742.
33. Yoburn BC, Shah S, Chan K, Duttaroy A, Davis T (1995) Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity. Pharmacol Biochem Behav 51:535-539.